These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32612866)

  • 21. High-throughput pKa screening and prediction amenable for ADME profiling.
    Wan H; Ulander J
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):139-55. PubMed ID: 16863474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Progress on Mass Spectrum Based Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Traditional Chinese Medicine.
    Bai X; Zhu C; Chen J; Jiang X; Jin Y; Shen R; Zhu M; Wu C
    Curr Drug Metab; 2022; 23(2):99-112. PubMed ID: 35152864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
    Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection.
    Balani SK; Miwa GT; Gan LS; Wu JT; Lee FW
    Curr Top Med Chem; 2005; 5(11):1033-8. PubMed ID: 16181128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
    Ekins S; Boulanger B; Swaan PW; Hupcey MA
    Mol Divers; 2002; 5(4):255-75. PubMed ID: 12549676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
    Ekins S; Boulanger B; Swaan PW; Hupcey MA
    J Comput Aided Mol Des; 2002; 16(5-6):381-401. PubMed ID: 12489686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery.
    Wan H; Holmén AG
    Comb Chem High Throughput Screen; 2009 Mar; 12(3):315-29. PubMed ID: 19275537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An integrated bioanalytical platform for supporting high-throughput serum protein binding screening.
    Zhang J; Shou WZ; Vath M; Kieltyka K; Maloney J; Elvebak L; Stewart J; Herbst J; Weller HN
    Rapid Commun Mass Spectrom; 2010 Dec; 24(24):3593-601. PubMed ID: 21080511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in high throughput screening for ADME properties.
    Carlson TJ; Fisher MB
    Comb Chem High Throughput Screen; 2008 Mar; 11(3):258-64. PubMed ID: 18336218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in high-throughput mass spectrometry in drug discovery.
    Dueñas ME; Peltier-Heap RE; Leveridge M; Annan RS; Büttner FH; Trost M
    EMBO Mol Med; 2023 Jan; 15(1):e14850. PubMed ID: 36515561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of machine learning and nonlinear statistical tools for ADME prediction.
    Sakiyama Y
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):149-69. PubMed ID: 19239395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving early drug discovery through ADME modelling: an overview.
    Wishart DS
    Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on bioanalytical mass spectrometry and automation in drug discovery.
    Janiszewski JS; Liston TE; Cole MJ
    Curr Drug Metab; 2008 Nov; 9(9):986-94. PubMed ID: 18991596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometry in drug discovery: a current review.
    Feng WY
    Curr Drug Discov Technol; 2004 Dec; 1(4):295-312. PubMed ID: 16472245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico predictions of ADME-Tox properties: drug absorption.
    Geerts T; Vander Heyden Y
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides: Physicochemical Characteristics and Beyond.
    Jiang R; Hooshfar S; Rebecca Eno M; Yun C; Sonego Zimmermann E; Shinkyo R
    Curr Drug Metab; 2023; 24(7):536-552. PubMed ID: 37076460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.